Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2012
04/19/2012US20120093951 Traditional chinese medicine composition for treating swine influenza, preparation method and use thereof
04/19/2012US20120093945 Method for treating an inflammation or lesion caused by a virus
04/19/2012US20120093938 Orally disintegrating tablets comprising diphenhydramine
04/19/2012US20120093920 Method of treatment for bladder dysfunction
04/19/2012US20120093911 Platinum-catalyzed intravaginal rings
04/19/2012US20120093910 Non-hormonal vaginal contraceptive
04/19/2012US20120093901 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of a cosmetic or pharmaceutical agent other than water
04/19/2012US20120093895 Bone-repair composition
04/19/2012US20120093890 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
04/19/2012US20120093884 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012US20120093875 Aminocyclitol compounds, process for obtaining them and uses
04/19/2012US20120093872 Method For Polypeptide Transfer Into Cells
04/19/2012US20120093870 Attenuated enterohemorrhagic e.coli-based vaccine vector and methods relating thereto
04/19/2012US20120093869 Live-attenuated compositions for bacterial infections
04/19/2012US20120093868 Haemophilus influenzae type b
04/19/2012US20120093867 GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis
04/19/2012US20120093865 Compositions comprising reduced genome bacteria for use in treatment of sepsis
04/19/2012US20120093864 Methods and Compositions for Polytopic Vaccination
04/19/2012US20120093863 Hcv vaccines and methods for using the same
04/19/2012US20120093862 Nucleic acid vaccines for prevention of flavivirus infection
04/19/2012US20120093861 Norovirus vaccine formulations
04/19/2012US20120093860 Influenza vaccines with increased amounts of h3 antigen
04/19/2012US20120093859 Influenza vaccine regimens for pandemic-associated strains
04/19/2012US20120093856 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
04/19/2012US20120093855 RSV F VLPs AND METHODS OF MANUFACTURE AND USE THEREOF
04/19/2012US20120093854 Use of mycoplasma bovis antigen
04/19/2012US20120093853 Simian Adenovirus Vectors and Methods of Use
04/19/2012US20120093851 Chlamydia antigens
04/19/2012US20120093850 Compositions for immunising against staphylococcus aureus
04/19/2012US20120093849 Agents for Treatment of HCV and Methods of Use
04/19/2012US20120093848 Immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
04/19/2012US20120093847 Recombinant rsv vaccines
04/19/2012US20120093844 Antimicrobial peptides based on cmap27
04/19/2012US20120093834 Neutralizing molecules to viral antigens
04/19/2012US20120093832 Promotion of neuronal integration in neural stem cell grafts
04/19/2012US20120093828 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
04/19/2012US20120093823 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
04/19/2012US20120093821 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093808 Humanized pcrv antibody having anti-pseudomonal activity
04/19/2012US20120093791 Stimulation of innate immunity with an antigen from bacterial origin
04/19/2012US20120093787 Methods and compositions for inhibiting viral entry into cells
04/19/2012US20120093776 Methods for treating diseases using a bone morphogenetic protein
04/19/2012US20120093770 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
04/19/2012US20120093767 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093766 Compounds for the Treatment of Hepatitis C
04/19/2012US20120093763 Rna virus infection inhibitor, method for inhibition of infection by rna virus, rna virus infection-inhibiting product, and use as rna virus infection inhibitor
04/19/2012US20120093760 Polyquaternium-1 synthesis methods
04/19/2012US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
04/19/2012US20120093738 Taste-masked oral formulations of influenza antivirals
04/19/2012US20120093729 Novel phosphorus-containing prodrugs
04/19/2012US20120093716 Use of antisecretory factors (af) for optimizing cellular uptake
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012CA2814673A1 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay
04/19/2012CA2814643A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012CA2814628A1 Acylbenzene derivative
04/19/2012CA2814175A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012CA2814092A1 Metal complexes of n-heterocyclic carbenes
04/19/2012CA2813783A1 Methods and compositions for inhibition of polymerase
04/19/2012CA2812779A1 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
04/18/2012EP2441493A1 Methods for producing an immune response to tuberculosis
04/18/2012EP2441470A1 Methods for producing an immune response to tuberculosis
04/18/2012EP2441469A1 Methods for producing an immune response to tuberculosis
04/18/2012EP2441443A1 Lactoferrin based complex coacervates and their uses
04/18/2012EP2440570A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
04/18/2012EP2440560A1 The succinate of tenofovir disoproxil
04/18/2012EP2440540A2 Antimicrobial polymers
04/18/2012EP2440536A1 Oxazole and thiazole derivatives as alx receptor agonists
04/18/2012EP2440535A1 Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
04/18/2012EP2440533A1 Guanine riboswitch binding compounds and their use as antibiotics
04/18/2012EP2440528A1 Heterocyclic antiviral compounds
04/18/2012EP2440523A1 High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
04/18/2012EP2440251A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
04/18/2012EP2440244A1 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
04/18/2012EP2440205A1 Iminosugars and methods of treating bunyaviral and togaviral diseases
04/18/2012EP2197477B1 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
04/18/2012EP1968620B1 Compositions comprising powdered garlic (Allium sativum linn.) and a concentrate of organic selenium compounds for nutritional supplementation
04/18/2012EP1960375B1 Novel macrolide compounds with antibiotic and antneoplastic properties
04/18/2012EP1499358B1 Ph-sensitive polymer
04/18/2012EP1390066B1 Vaccine composition
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012EP1207876B9 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing
04/18/2012EP1183368B1 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung
04/18/2012EP0618925B2 Antisense oligonucleotides
04/18/2012CN1969922B 一种复方药物组合物及其制备方法 A COMPOUND pharmaceutical composition and its preparation method
04/18/2012CN1958601B 八棱丝瓜蛋白1的快速分离纯化及其晶体生长技术 Luffaculin Rapid Purification and crystal growth technology 1
04/18/2012CN102421909A 聚酮化合物 Polyketide
04/18/2012CN102421443A 作为细胞因子活性调节剂的硫酸化的透明质酸 As sulfated hyaluronic acid cytokine activity modifiers
04/18/2012CN102417539A 抗菌蛋白及编码基因、表达体系、复性系统和应用 Antibacterial proteins and coding genes, expression systems, complex systems and applications
04/18/2012CN102417537A Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha
04/18/2012CN102417536A 一种抗口腔致龋菌的多肽Pm4及制备方法 An anti-peptide oral cariogenic bacteria and preparation methods Pm4
04/18/2012CN102417530A 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途 Synthesis method and use a broad-spectrum macrocyclic antibiotic erythromycin ketolide derivatives
04/18/2012CN102417516A 2-吡啶甲醛缩氨基硫脲希夫碱8-羟基喹啉类稀土三元配合物及其制备方法和应用 2- pyridinecarbaldehyde Thiosemicarbazone Schiff base 8-hydroxy quinoline-based rare-earth ternary complexes and its preparation method and application
04/18/2012CN102417515A 噻唑(嗪)烷酮并氮杂糖衍生物及合成方法和其在药物制剂中的应用 Thiazole (triazine) and the aza sugar oxazolidinone derivatives and their use in the synthesis methods and pharmaceutical formulations
04/18/2012CN102417502A 氮唑类抗真菌化合物、盐类及其制备方法和用途 Azole antifungal compounds, salts and their preparation and use
04/18/2012CN102417480A Spirocyclic nitriles as protease inhibitors
04/18/2012CN102417465A 替加环素新晶型及其制备方法 Tigecycline new crystal form and its preparation method
04/18/2012CN102416185A miR29在制备抗流感病毒药物中的应用 miR29 in the preparation of anti-influenza virus drug application
04/18/2012CN102416177A 鸡新城疫-H<sub>9</sub>亚型禽流感二联双佐剂灭活疫苗及其制备方法 Newcastle -H <sub> 9 </ sub> and avian influenza subtype double adjuvant inactivated vaccine and its preparation method
04/18/2012CN102416175A Medicament for treating HPV infection and application of medicament in preparation of medicament for treating HPV infection
1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 1798